OneMedNet Selects Palantir to Advance Healthcare AI and Data Analytics
DENVER and MINNEAPOLIS, Oct. 06, 2025 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) has selected Palantir Technologies (Nasdaq: PLTR) to transform the healthcare AI and Real-World Data (RWD) analytics marketplace. Palantir’s Artificial Intelligence Platform will provide the infrastructure for OneMedNet’s iRWD™ near real-time AI powered provider network (‘network’) enabling OneMedNet to empower life sciences, medical device, and research organizations with anonymized, regulatory-grade clinical data and advanced analytics to accelerate the development of cutting-edge medical solutions efficiently.
Access to healthcare data remains a key barrier to unlocking the $868 billion market opportunity in AI-driven healthcare by 20301. OneMedNet is positioned at the forefront by leveraging Palantir software to combine OneMedNet’s expansive provider network with Palantir’s advanced analytics, unlocking scalable recurring revenue opportunities on a secure, regulatory-grade platform.
Under the multi-year agreement, Palantir’s Artificial Intelligence Platform—renowned for enabling enterprises to unify complex datasets and enabling real-time insights—integrates with OneMedNet’s network, which provides access to more than 5 billion administrative claims and 131 million clinical exams across 1,750+ provider sites, spanning oncology, cardiology, and rare diseases.
Palantir’s software will be used to advance OneMedNet’s mission to bring the most current data to life sciences organizations decreasing costs and time to market for novel healthcare solutions.
“We’re proud to provide the AI infrastructure for OneMedNet to accelerate the delivery of transformative healthcare solutions that will ultimately improve patient outcomes,” said Drew Goldstein, Co-Head of Healthcare at Palantir.
Aaron Green, President and CEO of OneMedNet, added, “Palantir’s AIP helps us revolutionize our ability to deliver high-quality, regulatory-compliant data at remarkable speed. This positions us to power breakthroughs in clinical research and AI-driven healthcare solutions.”
- /de/en/industries/pharma-life-sciences/ai-healthcare-revolution.html
Impact of Palantir’s Artificial Intelligence Platform
- Faster Data Discovery: Customer data inquiries fulfilled in minutes instead of days, boosting OneMedNet’s ability to win orders with speed and precision.
- Accurate Data Delivery: Customers will be able to create custom cohorts, ensuring every data element aligns with their fit-for-purpose needs and remains fully relevant to their studies.
- Conversational Search: A new AI-powered interface, enabled by Palantir’s AIP and LLMs, allows subscribers to search, modify and zero in on the data they need across vast datasets.
- Increased Productivity: Automation to improve OneMedNet’s efficiency and reduce costs, enabling scalable growth with improved margins.
- Healthcare Standards Integration: Palantir’s ontology, paired with SNOMED, HCPCS, ICD-10, and CPT codes, ensures interoperable data access for life sciences users.
- Anonymization: OneMedNet’s proprietary AI algorithms to operate at scale on Palantir’s advanced platform to securely de-identify clinical data, ensuring regulatory compliance and protecting against exposure of Protected Health Information (PHI).
OneMedNet’s Objectives
- Market Expansion: OneMedNet is expanding its market reach and independently broadening its global footprint to deliver enhanced value to its customer base.
- Data Cohorts: Combining OneMedNet’s multimodal regulatory-grade data with Palantir’s AI platform to build regulatory grade data cohorts for use in diagnostics, therapeutics, and personalized medicine.
- Clinical Research: Streamlining trials with multimodal, longitudinal data for faster, more cost-effective outcomes.
- Scalable Analytics: Creating a secure platform for tailored, compliant datasets, leveraging OneMedNet’s real-time AI powered federated provider network and Palantir’s data expertise.
About Palantir Technologies
Software that dominates. Additional information is available at .
About OneMedNet Corporation
OneMedNet is revolutionizing how the world unlocks Real-World Data (RWD), harnessing the untapped potential of over 1,750 healthcare sites through its iRWD™ platform. This isn’t just multi-modal data—it’s the lifeblood of innovation, from de-identified medical imaging to electronic health records, fueling breakthroughs for drugmakers, medical device pioneers, and AI visionaries. With a network spanning rare diseases, oncology, cardiology, and beyond, OneMedNet delivers precision insights that redefine patient care and power the next wave of healthcare disruption.
Beyond healthcare OneMedNet’s proprietary AI anonymizes data for industries like finance, retail, and telecom, unlocking endless possibilities—rigorously testing production system upgrades, de-risking complex projects, and securely sharing sensitive data by stripping out personal information. Learn more at .
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical facts contained in this press release are forward-looking statements. These statements may relate to, but are not limited to, expectations regarding the expected benefits of the software platform and the partnership between Palantir and OneMedNet.. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. Forward-looking statements are based on information available at the time those statements are made and were based on current expectations as well as the beliefs and assumptions of management as of that time with respect to future events. These statements are subject to risks and uncertainties, many of which involve factors or circumstances that are beyond our control. These risks and uncertainties and additional information regarding these and other risks and uncertainties is included in the filings each company makes with the Securities and Exchange Commission from time to time. Except as required by law, neither company undertakes any obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future developments, or otherwise.
Media Contacts
Palantir Technologies
Lisa Gordon
OneMedNet Contacts:
Michael Wong, VP Marketing
Email:
